GlassScriptPhysician profile
William L Benedict
NPI 1063598548
$599.13
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $142 · 2021: $88.48 · 2023: $19.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $149.91 | 2019 | |
| Allergan, INC. | $107.82 | 2019-2021 | |
| Genentech, INC. | $86.85 | 2019-2020 | |
| Eyepoint US, INC. | $35.88 | 2019-2020 | |
| Spark Therapeutics, INC. | $35.23 | 2019-2021 | |
| Ocular Therapeutix, INC. | $34.57 | 2020 | |
| Genentech USA, INC. | $30.84 | 2020-2021 | |
| Alimera Sciences, INC. | $30.65 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $19.77 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $19.60 | 2023 | Eylea |
| Optos, INC. | $15.55 | 2019 | |
| Notal Vision, INC. | $12.23 | 2019 | |
| Heidelberg Engineering, INC. | $11.79 | 2021 | |
| Rxsight INC | $8.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Benedict listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.